Global (68M) cardiomyopathies market set to reach $9.63 bn by 2031: GlobalData

The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%

Viatris acquires Oyster Point Pharma and Famy Life Sciences

Acquisitions have the potential to add at least $1 billion in sales by 2028

Harbor Healthcare advises a California long-term care pharmacy on its sale & strategic partnership

The strategic acquirer maintains a nationwide presence in the LTC pharmacy space

CNS Pharmaceuticals appoints Faith L. Charles as Chair of the Board of Directors

Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations

Alniche Life Sciences launches #GutHealthAwareness campaign

Having a healthy gut is key as it permits the body to build a stronger immune system

Cipla EU to invest € 15 million in Ethris

Cipla and Ethris partner for the development of mRNA-based therapies

Stelis Biopharma’s CDMO partner receives approval for key ANDA from the USFDA

The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore

Advent International to acquire a significant stake in Suven Pharmaceuticals

Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.

GSK announces new global headquarters in central London

Company to open new headquarters in 2024

High demand leaves Ozempic compensating for Wegovy’s supply shortage: GlobalData